About Drug Target Review

From the industry experts and publishing team behind European Pharmaceutical Review, Drug Target Review provides a voice for the drug discovery industry, promoting the latest research and developments, funding projects, and cutting-edge technological developments.

Drug Target Review’s quarterly journal, website and annual events programme provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. 88% of our readers would recommend Drug Target Review to a friend or colleague.

We support academia, campus companies, tech transfers, research facilities and Pharma by creating a community with the goal of educating and sharing information and news. This community of diverse individuals is able to keep up to speed with research, news and funding as it happens through print, online and workshops.

Choose your free membership option and experience for yourself why thousands of pharmaceutical and life science professionals have already joined the Drug Target Review community. Membership entitles to you a free subscription to our print and/or digital magazine, as well as unrestricted access to our website, offering the latest articles, application notes and webinars.

Our team

Meet the team who manage & contribute to Drug Target Review:

• Nic Losardo, Editor-in-Chief
• Fraser Owen, Business Development Manager
• Ivelina Nedkova, Marketing Manager
• Victoria Rees, Deputy Editor
• Chanel Roffey, Marketing Assistant
• Caitlin Edley, Marketing Assistant
• Angelica Molas, Marketing Assistant

If you wish to contact us in respect of employment opportunities, please email us on careers@russellpublishing.com and a member of our HR team may then contact you in relation to any vacancies we have. For details on how your personal information will be processed we have a Candidate Privacy Policy which you can view here.

Published by Russell Publishing Ltd

Russell Publishing Ltd is a leading international publisher across a range of quarterly, bi-monthly and monthly titles from finance to pharmaceuticals, food to transport. 

Established since 1992, each title enjoys wide sector recognition by both advertisers and subscribers alike. In addition to our leading publications, throughout the year we are responsible for producing conferences, roundtable discussions, newsletters and supplements for the industries we serve. Each of these products contribute towards the overall strategy of becoming an indispensable partner to all of our target customers. For further information on Russell Publishing Ltd, please visit www.russellpublishing.com

Advisory Board

Pushpanathan Muthuirulan (Research Associate, Harvard University)

Richard Goodwin (Principal Scientist, Drug Safety and Metabolism, AstraZeneca)

Hamish Ryder (Director of Drug Discovery at Cancer Research UK Therapeutic Discovery Laboratories)

Sheraz Gul (Head of Drug Discovery at the Fraunhofer Institute)

Anton Simeonov (Acting Branch Chief and Group Leader, National Institutes of Health)

Horst Flotow (Senior Director, Business Development and Research Collaborations, HitGen Inc.)

Michelle Arkin (Associate Director, Biology, Small Molecule Discovery Center, University of California)

Giovanna Zinzalla (Assistant Professor in Chemical Biology, Karolinska Institutet)

Kamyar Hadian (Head of Assay Development and Screening Platform, Helmholtz Zentrum München)

James Adjaye (Chair of Stem Cell Research and Regenerative Medicine, Heinrich Heine University)

Justin Bryans (Executive Director of Drug Discovery at LifeArc)

Ulrich Schopfer (Executive Director, Integrated Lead Discovery Head, Novartis)